ZF Health&PharmaSummit 2017

Popescu, ARPIM: Patients’ Access To Innovative Drugs Still Is 1 To 10 In Romania Vs Western Europe

09.13.2017 By Ecaterina Craciun

The access to innovative medical drugs is still reduced, as the ratio between Romania and Western Europe remained 1 to 10, Liviu Popescu, director of external relations of the Romanian Association of International Drug Manufacturers (ARPIM), said on Wednesday.



To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
ARPIM
, innovative drugs